Syapse Hosts Inaugural Precision Medicine Council to Drive Progress in Precision Oncology

San Francisco, California, UNITED STATES

Nation’s leading health systems convene today to share best practices and improve cancer care

SAN FRANCISCO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Syapse, the leading precision medicine company, is convening innovative health systems today in San Francisco for the inaugural Syapse Precision Medicine Council, a group of healthcare leaders dedicated to advancing precision oncology through sharing best practices.

For the next two days, 35 participants from more than a dozen health systems from across the United States and South Korea will share strategies and insights for growing precision medicine programs and ensuring that more people have access to molecular tests and clinical trials.

“We formed the Syapse Precision Medicine Council to facilitate the exchange of concrete lessons and build on the rapid progress and growth of precision medicine,” said Ken Tarkoff, CEO of Syapse. “Today, I am thrilled that we are taking the next step by coming together in San Francisco and working to give all patients timely access to targeted treatment options.”

The Syapse Precision Medicine Council is focused on three primary goals: sharing early experiences in growing precision medicine programs, generating actionable insights to advance the industry as a whole, and building upon current data sharing initiatives. In a recent blog post, Dennis Shin, Chief Commercial Officer of Syapse, shared more information about the Council and how health systems will work toward these goals.

The event caps off months of research by the Syapse team into the strategic goals driving the launch of precision medicine programs and the design choices health systems with precision medicine programs have made. Syapse will convene the meeting by presenting findings from the research, and will follow with a series of working sessions on three key topics identified by health systems:

  • Clinical research in the era of precision medicine
  • Leveraging real world evidence in clinical practice
  • Demonstrating the value of a precision medicine program

The inaugural meeting comes on the heels of the Biden Cancer Summit in September, when Syapse doubled down on its commitment to expand data sharing by announcing that six more health systems committed to sharing data upon joining the Syapse Learning Health Network.

Following the Syapse Precision Medicine Council, the participants will collaborate to publish insights generated from the meeting to further advance the field of precision medicine.

Syapse plans to hold the Council annually, with future meetings potentially hosted at partner health systems.

About Syapse
Syapse is on a mission to deliver the best care for every cancer patient through precision medicine. Our software platform, data sharing network, and industry partnerships enable healthcare providers to bring precision cancer care to every patient who needs it. By bringing together leading healthcare innovators into a unified ecosystem, we are working toward a future in which all cancer patients have access to the best personalized care, regardless of location or income. Our customers—including Aurora Health Care, Catholic Health Initiatives, Dignity Health, Henry Ford Health System, Intermountain Healthcare, Providence St. Joseph Health, and Seoul National University Hospital—manage one million active cancer cases at nearly 300 hospitals in 25 states and South Korea.

Courtney Lamie
Crosscut Strategies